Oral Microbiome and Head & Neck Cancer: Biomarker, Driver, or Bystander?
09-10, 08:00–09:00 (Europe/Istanbul), Head & Neck Surgery 1

Moderator-Speaker Moderator-Speaker

Anastasios Maniakas, M.D., PhD., is an Assistant Professor, Tenure Track, in the Department of Head and Neck Surgery at The University of Texas MD Anderson Cancer Center. Dr. Maniakas received his undergraduate, master’s, and doctoral degrees from McGill University, and his medical doctorate from the University of Montreal. He completed his residency at the University of Montreal followed by a fellowship in head and neck surgical oncology at The University of Texas MD Anderson Cancer Center. His clinical expertise is in head and neck cancers, with an emphasis on thyroid disease, oral cavity cancer, skin cancers, and salivary gland neoplasms. Dr. Maniakas’ research interests focus on translational research, developing unique patient-derived xenograft models utilized in understanding cancer pathogenesis and novel drug therapy development. Furthermore, Dr. Maniakas is investigating the effect of the microbiome in the development, progression, and recurrence of cancer in his patient population. Lastly, he is co-leading a global randomized trial evaluating the effect of photoimmunotherapy in locoregionally advanced head and neck squamous cell carcinoma.

This speaker also appears in:

I am an Otolaryngology–Head and Neck Surgery specialist working at Ankara University, Department of Otorhinolaryngology.

This speaker also appears in:

Professor Chan is currently Clinical Professor and Chairman of the Department of Otorhinolaryngology, Head and Neck Surgery. He also is the Assistant Dean (Student Development) for the Faculty of Medicine. With a global perspective following graduating from Guy’s, King’s and St Thomas’ School of Medicine in London, specialist training in Otolaryngology, Head and Neck surgery at the Johns Hopkins Medical Institutions with advanced training in Head and Neck surgery, microvascular reconstruction and robotics.Professor Chan’s clinical expertise covers the full breadth of head and neck surgery, including a focus on minimally invasive approaches, in particular, transoral robotic approaches for head and neck tumours. His current area of research is focused on the role of the microbiome in head and neck cancers and the development of endoluminal robotics in surgery for which he has received numerous grants and Co-Founded a robotics startup - Agilis Robotics Ltd. In addition, he serves on the editorial board of the Journal of Otolaryngology -Head and Neck Surgery, the official journal of the Canadian Society of Otolaryngology - Head and Neck Surgery, and has over 100 peer reviewed published journal articles.

This speaker also appears in:

Dr. Arquiza is a Clinical Associate Professor at the University of the Philippines College of Medicine. She has served as president of the Philippine Society of Otolaryngology-Head and Neck Surgery and is currently a member of the Executive Committee of the Asia-Pacific Society of Thyroid Surgery.

This speaker also appears in:

Dr. Eddy Wong is a medical professional who graduated from the medical faculty of The Chinese University of Hong Kong (CUHK). Following his graduation, he embarked on his specialist training in Otorhinolaryngology (ENT) at the United Christian Hospital and the Prince of Wales Hospital (PWH). In 2009, he successfully completed his training and was appointed as a Fellow of the Hong Kong College of Otorhinolaryngologists.

Presently, Dr. Wong holds positions within the medical community, including President at The Hong Kong College of Otorhinolaryngologists, Chief of Service for the Department of ENT at Prince of Wales Hospital. He also serves as the Chief of the Division of Head & Neck within the Department of Otorhinolaryngology, Head & Neck Surgery at The Chinese University of Hong Kong.